StonvexLoading…
StonvexStonvexStonvexCore line items from TRAW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2024 2024-09-30 | Q3 2023 2023-09-30 |
|---|---|---|
Revenue | $170.00K | $170.00K |
Operating Income | $-137.10M | $-15.84M |
Net Income | $-136.60M | $-14.76M |
EPS (Diluted) | $-31.86 | $-17.59 |
Total Assets | $8.94M | $27.04M |
Total Liabilities | $10.97M | $12.52M |
Cash & Equivalents | $5.41M | $25.24M |
Free Cash Flow OCF − CapEx | $-29.40M | $-13.52M |
Shares Outstanding | 3.03M | 21.00M |